New Hampshire’s Bio X Cell, which has made a name for itself over the past quarter-century cranking out functional antibodies for in vivo research, is embarking on the next leg of its international expansion with the christening of a new facility in Asia.
Bio X Cell on Tuesday announced that it’s opened the doors to a new distribution center in Beijing.
The Beijing site adds to a growing footprint for the company, which also boasts a distribution center in Germany alongside its headquarters and manufacturing home base in Lebanon, New Hampshire.
Bio X Cell figures the new facility will boost its work with researchers and academic institutions across China by beefing up inventory availability and hastening order fulfillment.
The company did not disclose how much it invested in the new distribution center.
As it stands, Bio X Cell runs its entire manufacturing operation out of its primary facility in New Hampshire, which is located near Dartmouth College in the town of Hanover. The company says this approach gives its “complete oversight” over production, testing and quality control while ensuring that its antibody offerings are “always in stock and ready to ship.”
Overall, Bio X Cell says it offers its customers access to a library of more than 600 functional-grade antibodies. The company’s products are used by academic institutions, government agencies and biopharma companies for a wide array of research applications including in oncology, immunology, neuroscience and infectious disease.
Bio X Cell has been in the functional antibody supply business for more than 25 years. The company states on its website that it currently offers its products through an international network of distributors serving more than 50 countries around the world.
Aside from centers in Germany and China, Bio X Cell also operate distribution sites out of Singapore and Korea, the company noted in a press release.
"This new distribution center underscores our commitment to delivering high-quality functional antibodies to researchers worldwide with greater efficiency and reliability," Chris Conway, Bio X Cell’s CEO, said in a statement. "With increased inventory on hand in Beijing, we can reduce lead times and provide faster access to the essential reagents that fuel groundbreaking scientific discoveries."
Conway, for his part, joined Bio X Cell last summer, taking over for the company’s founder, Klaus Lubbe. Conway joined Bio X Cell from the CDMO Curia, where he most recently led the manufacturer’s research and development wing as president.